FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2883265053> ?p ?o ?g. }

• W2883265053 endingPage "1898" @default.
• W2883265053 startingPage "1883" @default.
• W2883265053 abstract "The introduction of novel agents in the management of multiple myeloma and related plasma cell dyscrasias has changed our treatment approaches and subsequently the outcome of patients. Due to current advances, the European Myeloma Network updated the diagnostic and therapeutic recommendations for patients with Waldenström’s macroglobulinemia (WM), AL-amyloidosis, monoclonal immunoglobulin deposition disease (MIDD), POEMS syndrome, and primary plasma cell leukemia. For patients with WM, the combination of rituximab with chemotherapy remains the treatment cornerstone, while the Bruton-tyrosine kinase inhibitor ibrutinib has been introduced and approved for relapsed/refractory disease. The management of light chain amyloidosis depends on the presence and severity of heart disfunction. If present, intensification with an autologous stem cell transplantation (ASCT) is not recommended. Further aggregation of misfolded light chains could be prevented by doxycycline or monoclonal antibodies targeting amyloid deposits. Initial treatment generally consists of melphalan/dexamethasone or bortezomib-based regimens. For relapsing patients, one can consider proteasome inhibitors, immunomodulatory agents, melphalan or daratumumab. Because intact or light-chain immunoglobulins are also the culprits for MIDD, the small monoclonal plasma cells' clones should be treated and generally respond well to bortezomib-based treatment. POEMS syndrome is a well-defined clinical entity that can present as solitary bone lesions or disseminated disease. Radiation therapy is used for patients with localized disease and result in long-lasting response. Systemic treatment should be proposed to patients with disseminated disease, but regimens that can worsen a pre-existing polyneuropathy should be avoided. PPCL is located at the other end of the spectrum of plasma cell disorders and is associated with an aggressive disease course and poor prognosis. It requires an imminent, multi-phase and novel agents-based therapy, including induction, ASCT, consolidation and maintenance, with short treatment-free intervals. Patients not eligible for transplant procedures require personalized, intensive therapeutic approach. Allogeneic stem cell transplantation can be used in selected patients." @default.
• W2883265053 created "2018-08-03" @default.
• W2883265053 creator A5002972322 @default.
• W2883265053 creator A5005713464 @default.
• W2883265053 creator A5016360607 @default.
• W2883265053 creator A5018139001 @default.
• W2883265053 creator A5018522443 @default.
• W2883265053 creator A5038143009 @default.
• W2883265053 creator A5041407463 @default.
• W2883265053 creator A5044869604 @default.
• W2883265053 creator A5061635623 @default.
• W2883265053 creator A5063647828 @default.
• W2883265053 creator A5069712875 @default.
• W2883265053 creator A5077620734 @default.
• W2883265053 creator A5083385949 @default.
• W2883265053 creator A5085821633 @default.
• W2883265053 creator A5088691462 @default.
• W2883265053 creator A5090460126 @default.
• W2883265053 date "2018-07-23" @default.
• W2883265053 modified "2023-10-15" @default.
• W2883265053 title "European myeloma network recommendations on diagnosis and management of patients with rare plasma cell dyscrasias" @default.
• W2883265053 cites W146910030 @default.
• W2883265053 cites W1486630464 @default.
• W2883265053 cites W150778959 @default.
• W2883265053 cites W1529714767 @default.
• W2883265053 cites W1760770217 @default.
• W2883265053 cites W1818751554 @default.
• W2883265053 cites W1896238496 @default.
• W2883265053 cites W1909920751 @default.
• W2883265053 cites W1949051914 @default.
• W2883265053 cites W1964239136 @default.
• W2883265053 cites W1971493542 @default.
• W2883265053 cites W1976156505 @default.
• W2883265053 cites W1976173754 @default.
• W2883265053 cites W1978930370 @default.
• W2883265053 cites W1983182895 @default.
• W2883265053 cites W1986840808 @default.
• W2883265053 cites W1988113294 @default.
• W2883265053 cites W1990220334 @default.
• W2883265053 cites W2002324468 @default.
• W2883265053 cites W2003426156 @default.
• W2883265053 cites W2003599195 @default.
• W2883265053 cites W2009073165 @default.
• W2883265053 cites W2012580507 @default.
• W2883265053 cites W2012680794 @default.
• W2883265053 cites W2016201763 @default.
• W2883265053 cites W2017612047 @default.
• W2883265053 cites W2018928569 @default.
• W2883265053 cites W2027076242 @default.
• W2883265053 cites W2030131482 @default.
• W2883265053 cites W2032048924 @default.
• W2883265053 cites W2032758261 @default.
• W2883265053 cites W2033793452 @default.
• W2883265053 cites W2038193784 @default.
• W2883265053 cites W2040978620 @default.
• W2883265053 cites W2043831614 @default.
• W2883265053 cites W2047090819 @default.
• W2883265053 cites W2049365670 @default.
• W2883265053 cites W2053682062 @default.
• W2883265053 cites W2058789242 @default.
• W2883265053 cites W2060645589 @default.
• W2883265053 cites W2060957671 @default.
• W2883265053 cites W2063772107 @default.
• W2883265053 cites W2070335603 @default.
• W2883265053 cites W2070653024 @default.
• W2883265053 cites W2077646176 @default.
• W2883265053 cites W2080120607 @default.
• W2883265053 cites W2082169216 @default.
• W2883265053 cites W2091319225 @default.
• W2883265053 cites W2092679212 @default.
• W2883265053 cites W2095561966 @default.
• W2883265053 cites W2096562853 @default.
• W2883265053 cites W2099349054 @default.
• W2883265053 cites W2101761743 @default.
• W2883265053 cites W2105147470 @default.
• W2883265053 cites W2106411455 @default.
• W2883265053 cites W2107403553 @default.
• W2883265053 cites W2108020531 @default.
• W2883265053 cites W2109587991 @default.
• W2883265053 cites W2112889395 @default.
• W2883265053 cites W2117582823 @default.
• W2883265053 cites W2119071301 @default.
• W2883265053 cites W2123789589 @default.
• W2883265053 cites W2124473981 @default.
• W2883265053 cites W2128536827 @default.
• W2883265053 cites W2130647510 @default.
• W2883265053 cites W2133192145 @default.
• W2883265053 cites W2133838188 @default.
• W2883265053 cites W2137477100 @default.
• W2883265053 cites W2139100518 @default.
• W2883265053 cites W2143496573 @default.
• W2883265053 cites W2144086680 @default.
• W2883265053 cites W2147055495 @default.
• W2883265053 cites W2148009655 @default.
• W2883265053 cites W2148197707 @default.
• W2883265053 cites W2159694977 @default.
• W2883265053 cites W2160940401 @default.
• W2883265053 cites W2161231801 @default.

• next